To determine if the elevated luminal BAs observed in NEC [10] decrease ileal Muc2, neonatal rats subjected to the NEC protocol were given cholestyramine (Chol), a compound that binds BAs in the intestinal lumen. This evidence concerns the gene MUC2 and necrotizing enterocolitis.